United States Multivalent Vaccines Market Report 2018

United States Multivalent Vaccines Market Report 2018

1 Multivalent Vaccines Overview

1.1 Product Overview and Scope of Multivalent Vaccines

1.2 Classification of Multivalent Vaccines by Product Category

1.2.1 United States Multivalent Vaccines Market Size (Sales Volume) Comparison by Type (2013-2025)

1.2.2 United States Multivalent Vaccines Market Size (Sales Volume) Market Share by Type (Product Category) in 2017

1.2.3 Conjugate Vaccines

1.2.4 Inactivated and Subunit Vaccines

1.2.5 Live Attenuated Vaccines

1.2.6 Toxoid Vaccines

1.2.7 Recombinant Vaccines

1.3 United States Multivalent Vaccines Market by Application/End Users

1.3.1 United States Multivalent Vaccines Market Size (Consumption) and Market Share Comparison by Application (2013-2025)

1.3.2 Pediatrics

1.3.3 Adults

1.4 United States Multivalent Vaccines Market by Region

1.4.1 United States Multivalent Vaccines Market Size (Value) Comparison by Region (2013-2025)

1.4.2 The West Multivalent Vaccines Status and Prospect (2013-2025)

1.4.3 Southwest Multivalent Vaccines Status and Prospect (2013-2025)

1.4.4 The Middle Atlantic Multivalent Vaccines Status and Prospect (2013-2025)

1.4.5 New England Multivalent Vaccines Status and Prospect (2013-2025)

1.4.6 The South Multivalent Vaccines Status and Prospect (2013-2025)

1.4.7 The Midwest Multivalent Vaccines Status and Prospect (2013-2025)

1.5 United States Market Size (Value and Volume) of Multivalent Vaccines (2013-2025)

1.5.1 United States Multivalent Vaccines Sales and Growth Rate (2013-2025)

1.5.2 United States Multivalent Vaccines Revenue and Growth Rate (2013-2025)

2 United States Multivalent Vaccines Market Competition by Players/Suppliers

2.1 United States Multivalent Vaccines Sales and Market Share of Key Players/Suppliers (2013-2018)

2.2 United States Multivalent Vaccines Revenue and Share by Players/Suppliers (2013-2018)

2.3 United States Multivalent Vaccines Average Price by Players/Suppliers (2013-2018)

2.4 United States Multivalent Vaccines Market Competitive Situation and Trends

2.4.1 United States Multivalent Vaccines Market Concentration Rate

2.4.2 United States Multivalent Vaccines Market Share of Top 3 and Top 5 Players/Suppliers

2.4.3 Mergers & Acquisitions, Expansion in United States Market

2.5 United States Players/Suppliers Multivalent Vaccines Manufacturing Base Distribution, Sales Area, Product Type

3 United States Multivalent Vaccines Sales (Volume) and Revenue (Value) by Region (2013-2018)

3.1 United States Multivalent Vaccines Sales and Market Share by Region (2013-2018)

3.2 United States Multivalent Vaccines Revenue and Market Share by Region (2013-2018)

3.3 United States Multivalent Vaccines Price by Region (2013-2018)

4 United States Multivalent Vaccines Sales (Volume) and Revenue (Value) by Type (Product Category) (2013-2018)

4.1 United States Multivalent Vaccines Sales and Market Share by Type (Product Category) (2013-2018)

4.2 United States Multivalent Vaccines Revenue and Market Share by Type (2013-2018)

4.3 United States Multivalent Vaccines Price by Type (2013-2018)

4.4 United States Multivalent Vaccines Sales Growth Rate by Type (2013-2018)

5 United States Multivalent Vaccines Sales (Volume) by Application (2013-2018)

5.1 United States Multivalent Vaccines Sales and Market Share by Application (2013-2018)

5.2 United States Multivalent Vaccines Sales Growth Rate by Application (2013-2018)

5.3 Market Drivers and Opportunities

6 United States Multivalent Vaccines Players/Suppliers Profiles and Sales Data

6.1 GlaxoSmithKline, plc (U.K.)

6.1.1 Company Basic Information, Manufacturing Base and Competitors

6.1.2 Multivalent Vaccines Product Category, Application and Specification

6.1.2.1 Product A

6.1.2.2 Product B

6.1.3 GlaxoSmithKline, plc (U.K.) Multivalent Vaccines Sales, Revenue, Price and Gross Margin (2013-2018)

6.1.4 Main Business/Business Overview

6.2 Pfizer, Inc. (U.S.)

6.2.2 Multivalent Vaccines Product Category, Application and Specification

6.2.2.1 Product A

6.2.2.2 Product B

6.2.3 Pfizer, Inc. (U.S.) Multivalent Vaccines Sales, Revenue, Price and Gross Margin (2013-2018)

6.2.4 Main Business/Business Overview

6.3 Merck & Co., Inc. (U.S.)

6.3.2 Multivalent Vaccines Product Category, Application and Specification

6.3.2.1 Product A

6.3.2.2 Product B

6.3.3 Merck & Co., Inc. (U.S.) Multivalent Vaccines Sales, Revenue, Price and Gross Margin (2013-2018)

6.3.4 Main Business/Business Overview

6.4 Sanofi Pasteur SA (France)

6.4.2 Multivalent Vaccines Product Category, Application and Specification

6.4.2.1 Product A

6.4.2.2 Product B

6.4.3 Sanofi Pasteur SA (France) Multivalent Vaccines Sales, Revenue, Price and Gross Margin (2013-2018)

6.4.4 Main Business/Business Overview

6.5 Astellas Pharma Inc. (Japan)

6.5.2 Multivalent Vaccines Product Category, Application and Specification

6.5.2.1 Product A

6.5.2.2 Product B

6.5.3 Astellas Pharma Inc. (Japan) Multivalent Vaccines Sales, Revenue, Price and Gross Margin (2013-2018)

6.5.4 Main Business/Business Overview

6.6 CSL Limited (Australia)

6.6.2 Multivalent Vaccines Product Category, Application and Specification

6.6.2.1 Product A

6.6.2.2 Product B

6.6.3 CSL Limited (Australia) Multivalent Vaccines Sales, Revenue, Price and Gross Margin (2013-2018)

6.6.4 Main Business/Business Overview

6.7 Emergent BioSolutions, Inc. (U.S.)

6.7.2 Multivalent Vaccines Product Category, Application and Specification

6.7.2.1 Product A

6.7.2.2 Product B

6.7.3 Emergent BioSolutions, Inc. (U.S.) Multivalent Vaccines Sales, Revenue, Price and Gross Margin (2013-2018)

6.7.4 Main Business/Business Overview

6.8 Johnson & Johnson (U.S.)

6.8.2 Multivalent Vaccines Product Category, Application and Specification

6.8.2.1 Product A

6.8.2.2 Product B

6.8.3 Johnson & Johnson (U.S.) Multivalent Vaccines Sales, Revenue, Price and Gross Margin (2013-2018)

6.8.4 Main Business/Business Overview

6.9 MedImmune, LLC (U.S.)

6.9.2 Multivalent Vaccines Product Category, Application and Specification

6.9.2.1 Product A

6.9.2.2 Product B

6.9.3 MedImmune, LLC (U.S.) Multivalent Vaccines Sales, Revenue, Price and Gross Margin (2013-2018)

6.9.4 Main Business/Business Overview

6.10 Serum Institute of India Pvt. Ltd. (India)

6.10.2 Multivalent Vaccines Product Category, Application and Specification

6.10.2.1 Product A

6.10.2.2 Product B

6.10.3 Serum Institute of India Pvt. Ltd. (India) Multivalent Vaccines Sales, Revenue, Price and Gross Margin (2013-2018)

6.10.4 Main Business/Business Overview

6.11 Bavarian Nordic (Denmark)

6.12 Mitsubishi Tanabe Pharma Corporation (Japan)

6.13 Daiichi Sankyo (Japan)

6.14 Protein Sciences Corporation (U.S.)

6.15 Panacea Biotec (India)

7 Multivalent Vaccines Manufacturing Cost Analysis

7.1 Multivalent Vaccines Key Raw Materials Analysis

7.1.1 Key Raw Materials

7.1.2 Price Trend of Key Raw Materials

7.1.3 Key Suppliers of Raw Materials

7.1.4 Market Concentration Rate of Raw Materials

7.2 Proportion of Manufacturing Cost Structure

7.2.1 Raw Materials

7.2.2 Labor Cost

7.2.3 Manufacturing Expenses

7.3 Manufacturing Process Analysis of Multivalent Vaccines

8 Industrial Chain, Sourcing Strategy and Downstream Buyers

8.1 Multivalent Vaccines Industrial Chain Analysis

8.2 Upstream Raw Materials Sourcing

8.3 Raw Materials Sources of Multivalent Vaccines Major Manufacturers in 2017

8.4 Downstream Buyers

9 Marketing Strategy Analysis, Distributors/Traders

9.1 Marketing Channel

9.1.1 Direct Marketing

9.1.2 Indirect Marketing

9.1.3 Marketing Channel Development Trend

9.2 Market Positioning

9.2.1 Pricing Strategy

9.2.2 Brand Strategy

9.2.3 Target Client

9.3 Distributors/Traders List

10 Market Effect Factors Analysis

10.1 Technology Progress/Risk

10.1.1 Substitutes Threat

10.1.2 Technology Progress in Related Industry

10.2 Consumer Needs/Customer Preference Change

10.3 Economic/Political Environmental Change

11 United States Multivalent Vaccines Market Size (Value and Volume) Forecast (2018-2025)

11.1 United States Multivalent Vaccines Sales Volume, Revenue Forecast (2018-2025)

11.2 United States Multivalent Vaccines Sales Volume Forecast by Type (2018-2025)

11.3 United States Multivalent Vaccines Sales Volume Forecast by Application (2018-2025)

11.4 United States Multivalent Vaccines Sales Volume Forecast by Region (2018-2025)

12 Research Findings and Conclusion

13 Appendix

13.1 Methodology/Research Approach

13.1.1 Research Programs/Design

13.1.2 Market Size Estimation

13.1.3 Market Breakdown and Data Triangulation

13.2 Data Source

13.2.1 Secondary Sources

13.2.2 Primary Sources

13.3 Disclaimer

Figure Product Picture of Multivalent Vaccines

Figure United States Multivalent Vaccines Market Size (K Pcs) by Type (2013-2025)

Figure United States Multivalent Vaccines Sales Volume Market Share by Type (Product Category) in 2017

Figure Conjugate Vaccines Product Picture

Figure Inactivated and Subunit Vaccines Product Picture

Figure Live Attenuated Vaccines Product Picture

Figure Toxoid Vaccines Product Picture

Figure Recombinant Vaccines Product Picture

Figure United States Multivalent Vaccines Market Size (K Pcs) by Application (2013-2025)

Figure United States Sales Market Share of Multivalent Vaccines by Application in 2017

Figure Pediatrics Examples

Table Key Downstream Customer in Pediatrics

Figure Adults Examples

Table Key Downstream Customer in Adults

Figure United States Multivalent Vaccines Market Size (Million USD) by Region (2013-2025)

Figure The West Multivalent Vaccines Revenue (Million USD) and Growth Rate (2013-2025)

Figure Southwest Multivalent Vaccines Revenue (Million USD) and Growth Rate (2013-2025)

Figure The Middle Atlantic Multivalent Vaccines Revenue (Million USD) and Growth Rate (2013-2025)

Figure New England Multivalent Vaccines Revenue (Million USD) and Growth Rate (2013-2025)

Figure The South of US Multivalent Vaccines Revenue (Million USD) and Growth Rate (2013-2025)

Figure The Midwest Multivalent Vaccines Revenue (Million USD) and Growth Rate (2013-2025)

Figure United States Multivalent Vaccines Sales (K Pcs) and Growth Rate (2013-2025)

Figure United States Multivalent Vaccines Revenue (Million USD) and Growth Rate (2013-2025)

Figure United States Multivalent Vaccines Market Major Players Product Sales Volume (K Pcs) (2013-2018)

Table United States Multivalent Vaccines Sales (K Pcs) of Key Players/Suppliers (2013-2018)

Table United States Multivalent Vaccines Sales Share by Players/Suppliers (2013-2018)

Figure 2017 United States Multivalent Vaccines Sales Share by Players/Suppliers

Figure 2017 United States Multivalent Vaccines Sales Share by Players/Suppliers

Figure United States Multivalent Vaccines Market Major Players Product Revenue (Million USD) (2013-2018)

Table United States Multivalent Vaccines Revenue (Million USD) by Players/Suppliers (2013-2018)

Table United States Multivalent Vaccines Revenue Share by Players/Suppliers (2013-2018)

Figure 2017 United States Multivalent Vaccines Revenue Share by Players/Suppliers

Figure 2017 United States Multivalent Vaccines Revenue Share by Players/Suppliers

Table United States Market Multivalent Vaccines Average Price (USD/Pcs) of Key Players/Suppliers (2013-2018)

Figure United States Market Multivalent Vaccines Average Price (USD/Pcs) of Key Players/Suppliers in 2017

Figure United States Multivalent Vaccines Market Share of Top 3 Players/Suppliers

Figure United States Multivalent Vaccines Market Share of Top 5 Players/Suppliers

Table United States Players/Suppliers Multivalent Vaccines Manufacturing Base Distribution and Sales Area

Table United States Players/Suppliers Multivalent Vaccines Product Category

Table United States Multivalent Vaccines Sales (K Pcs) by Region (2013-2018)

Table United States Multivalent Vaccines Sales Share by Region (2013-2018)

Figure United States Multivalent Vaccines Sales Share by Region (2013-2018)

Figure United States Multivalent Vaccines Sales Market Share by Region in 2017

Table United States Multivalent Vaccines Revenue (Million USD) and Market Share by Region (2013-2018)

Table United States Multivalent Vaccines Revenue Share by Region (2013-2018)

Figure United States Multivalent Vaccines Revenue Market Share by Region (2013-2018)

Figure United States Multivalent Vaccines Revenue Market Share by Region in 2017

Table United States Multivalent Vaccines Price (USD/Pcs) by Region (2013-2018)

Table United States Multivalent Vaccines Sales (K Pcs) by Type (2013-2018)

Table United States Multivalent Vaccines Sales Share by Type (2013-2018)

Figure United States Multivalent Vaccines Sales Share by Type (2013-2018)

Figure United States Multivalent Vaccines Sales Market Share by Type in 2017

Table United States Multivalent Vaccines Revenue (Million USD) and Market Share by Type (2013-2018)

Table United States Multivalent Vaccines Revenue Share by Type (2013-2018)

Figure Revenue Market Share of Multivalent Vaccines by Type (2013-2018)

Figure Revenue Market Share of Multivalent Vaccines by Type in 2017

Table United States Multivalent Vaccines Price (USD/Pcs) by Types (2013-2018)

Figure United States Multivalent Vaccines Sales Growth Rate by Type (2013-2018)

Table United States Multivalent Vaccines Sales (K Pcs) by Application (2013-2018)

Table United States Multivalent Vaccines Sales Market Share by Application (2013-2018)

Figure United States Multivalent Vaccines Sales Market Share by Application (2013-2018)

Figure United States Multivalent Vaccines Sales Market Share by Application in 2017

Table United States Multivalent Vaccines Sales Growth Rate by Application (2013-2018)

Figure United States Multivalent Vaccines Sales Growth Rate by Application (2013-2018)

Table GlaxoSmithKline, plc (U.K.) Basic Information List

Table GlaxoSmithKline, plc (U.K.) Multivalent Vaccines Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)

Figure GlaxoSmithKline, plc (U.K.) Multivalent Vaccines Sales Growth Rate (2013-2018)

Figure GlaxoSmithKline, plc (U.K.) Multivalent Vaccines Sales Market Share in United States (2013-2018)

Figure GlaxoSmithKline, plc (U.K.) Multivalent Vaccines Revenue Market Share in United States (2013-2018)

Table Pfizer, Inc. (U.S.) Basic Information List

Table Pfizer, Inc. (U.S.) Multivalent Vaccines Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)

Figure Pfizer, Inc. (U.S.) Multivalent Vaccines Sales Growth Rate (2013-2018)

Figure Pfizer, Inc. (U.S.) Multivalent Vaccines Sales Market Share in United States (2013-2018)

Figure Pfizer, Inc. (U.S.) Multivalent Vaccines Revenue Market Share in United States (2013-2018)

Table Merck & Co., Inc. (U.S.) Basic Information List

Table Merck & Co., Inc. (U.S.) Multivalent Vaccines Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)

Figure Merck & Co., Inc. (U.S.) Multivalent Vaccines Sales Growth Rate (2013-2018)

Figure Merck & Co., Inc. (U.S.) Multivalent Vaccines Sales Market Share in United States (2013-2018)

Figure Merck & Co., Inc. (U.S.) Multivalent Vaccines Revenue Market Share in United States (2013-2018)

Table Sanofi Pasteur SA (France) Basic Information List

Table Sanofi Pasteur SA (France) Multivalent Vaccines Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)

Figure Sanofi Pasteur SA (France) Multivalent Vaccines Sales Growth Rate (2013-2018)

Figure Sanofi Pasteur SA (France) Multivalent Vaccines Sales Market Share in United States (2013-2018)

Figure Sanofi Pasteur SA (France) Multivalent Vaccines Revenue Market Share in United States (2013-2018)

Table Astellas Pharma Inc. (Japan) Basic Information List

Table Astellas Pharma Inc. (Japan) Multivalent Vaccines Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)

Figure Astellas Pharma Inc. (Japan) Multivalent Vaccines Sales Growth Rate (2013-2018)

Figure Astellas Pharma Inc. (Japan) Multivalent Vaccines Sales Market Share in United States (2013-2018)

Figure Astellas Pharma Inc. (Japan) Multivalent Vaccines Revenue Market Share in United States (2013-2018)

Table CSL Limited (Australia) Basic Information List

Table CSL Limited (Australia) Multivalent Vaccines Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)

Figure CSL Limited (Australia) Multivalent Vaccines Sales Growth Rate (2013-2018)

Figure CSL Limited (Australia) Multivalent Vaccines Sales Market Share in United States (2013-2018)

Figure CSL Limited (Australia) Multivalent Vaccines Revenue Market Share in United States (2013-2018)

Table Emergent BioSolutions, Inc. (U.S.) Basic Information List

Table Emergent BioSolutions, Inc. (U.S.) Multivalent Vaccines Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)

Figure Emergent BioSolutions, Inc. (U.S.) Multivalent Vaccines Sales Growth Rate (2013-2018)

Figure Emergent BioSolutions, Inc. (U.S.) Multivalent Vaccines Sales Market Share in United States (2013-2018)

Figure Emergent BioSolutions, Inc. (U.S.) Multivalent Vaccines Revenue Market Share in United States (2013-2018)

Table Johnson & Johnson (U.S.) Basic Information List

Table Johnson & Johnson (U.S.) Multivalent Vaccines Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)

Figure Johnson & Johnson (U.S.) Multivalent Vaccines Sales Growth Rate (2013-2018)

Figure Johnson & Johnson (U.S.) Multivalent Vaccines Sales Market Share in United States (2013-2018)

Figure Johnson & Johnson (U.S.) Multivalent Vaccines Revenue Market Share in United States (2013-2018)

Table MedImmune, LLC (U.S.) Basic Information List

Table MedImmune, LLC (U.S.) Multivalent Vaccines Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)

Figure MedImmune, LLC (U.S.) Multivalent Vaccines Sales Growth Rate (2013-2018)

Figure MedImmune, LLC (U.S.) Multivalent Vaccines Sales Market Share in United States (2013-2018)

Figure MedImmune, LLC (U.S.) Multivalent Vaccines Revenue Market Share in United States (2013-2018)

Table Serum Institute of India Pvt. Ltd. (India) Basic Information List

Table Serum Institute of India Pvt. Ltd. (India) Multivalent Vaccines Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)

Figure Serum Institute of India Pvt. Ltd. (India) Multivalent Vaccines Sales Growth Rate (2013-2018)

Figure Serum Institute of India Pvt. Ltd. (India) Multivalent Vaccines Sales Market Share in United States (2013-2018)

Figure Serum Institute of India Pvt. Ltd. (India) Multivalent Vaccines Revenue Market Share in United States (2013-2018)

Table Bavarian Nordic (Denmark) Basic Information List

Table Mitsubishi Tanabe Pharma Corporation (Japan) Basic Information List

Table Daiichi Sankyo (Japan) Basic Information List

Table Protein Sciences Corporation (U.S.) Basic Information List

Table Panacea Biotec (India) Basic Information List

Table Production Base and Market Concentration Rate of Raw Material

Figure Price Trend of Key Raw Materials

Table Key Suppliers of Raw Materials

Figure Manufacturing Cost Structure of Multivalent Vaccines

Figure Manufacturing Process Analysis of Multivalent Vaccines

Figure Multivalent Vaccines Industrial Chain Analysis

Table Raw Materials Sources of Multivalent Vaccines Major Players/Suppliers in 2017

Table Major Buyers of Multivalent Vaccines

Table Distributors/Traders List

Figure United States Multivalent Vaccines Sales Volume (K Pcs) and Growth Rate Forecast (2018-2025)

Figure United States Multivalent Vaccines Revenue (Million USD) and Growth Rate Forecast (2018-2025)

Figure United States Multivalent Vaccines Price (USD/Pcs) Trend Forecast (2018-2025)

Table United States Multivalent Vaccines Sales Volume (K Pcs) Forecast by Type (2018-2025)

Figure United States Multivalent Vaccines Sales Volume (K Pcs) Forecast by Type (2018-2025)

Figure United States Multivalent Vaccines Sales Volume (K Pcs) Forecast by Type in 2025

Table United States Multivalent Vaccines Sales Volume (K Pcs) Forecast by Application (2018-2025)

Figure United States Multivalent Vaccines Sales Volume (K Pcs) Forecast by Application (2018-2025)

Figure United States Multivalent Vaccines Sales Volume (K Pcs) Forecast by Application in 2025

Table United States Multivalent Vaccines Sales Volume (K Pcs) Forecast by Region (2018-2025)

Table United States Multivalent Vaccines Sales Volume Share Forecast by Region (2018-2025)

Figure United States Multivalent Vaccines Sales Volume Share Forecast by Region (2018-2025)

Figure United States Multivalent Vaccines Sales Volume Share Forecast by Region in 2025

Table Research Programs/Design for This Report

Figure Bottom-up and Top-down Approaches for This Report

Figure Data Triangulation

Table Key Data Information from Secondary Sources

Table Key Data Information from Primary Sources